Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST
Company Participants
David DeMartino – Senior Vice President of Investor Relations
Ivan Tornos – President, CEO & Chairman of the Board
Paul Stellato – Interim CFO, VP, Controller & Chief Accounting Officer
Conference Call Participants
Mathew Blackman – TD Cowen, Research Division
Frederick Wise – Stifel, Nicolaus & Company, Incorporated, Research Division
Patrick Andrew Wood – UBS Investment Bank, Research Division
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Travis Steed – BofA Securities, Research Division
Robert Marcus – JPMorgan Chase & Co, Research Division
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Matthew Taylor – Jefferies LLC, Research Division
Richard Newitter – Truist Securities, Inc., Research Division
Christopher Pasquale – Barclays PLC
Caitlin Cronin – Canaccord Genuity Corp., Research Division
Steven Lichtman – William Blair & Company L.L.C., Research Division
Zachary Gold – Raymond James & Associates, Inc., Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November 4, 2026. [Operator Instructions] I would now like to turn the conference over to David DeMartino, Senior Vice President, Investor Relations. Please go ahead.
David DeMartino
Senior Vice President of Investor Relations
Thank you, operator, and good morning, everyone. Welcome to Zimmer Biomet’s Third Quarter 2026 Earnings Conference Call. Joining me on today’s call are Ivan Tornos, our Chairman, President and CEO; and Paul Stellato, our Interim CFO and VP, Controller and Chief Accounting Officer.
Before we get started, I’d like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. For a detailed discussion of all these risks and uncertainties in addition
Credit: Source link
